SI1644389T1 - Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi - Google Patents

Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi

Info

Publication number
SI1644389T1
SI1644389T1 SI200431649T SI200431649T SI1644389T1 SI 1644389 T1 SI1644389 T1 SI 1644389T1 SI 200431649 T SI200431649 T SI 200431649T SI 200431649 T SI200431649 T SI 200431649T SI 1644389 T1 SI1644389 T1 SI 1644389T1
Authority
SI
Slovenia
Prior art keywords
nucleotide analogs
pyrimidine compounds
phosphonate groups
sub
antiviral nucleotide
Prior art date
Application number
SI200431649T
Other languages
English (en)
Inventor
Jan Marie Rene Balzarini
Clercq Erik Desire Alice De
Dana Hockova
Antonin Holy
Original Assignee
Acad Of Science Czech Republic
Leuven K U Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic, Leuven K U Res & Dev filed Critical Acad Of Science Czech Republic
Publication of SI1644389T1 publication Critical patent/SI1644389T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
SI200431649T 2003-06-16 2004-06-16 Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi SI1644389T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47889303P 2003-06-16 2003-06-16
EP04738454A EP1644389B1 (en) 2003-06-16 2004-06-16 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
PCT/CZ2004/000034 WO2004111064A1 (en) 2003-06-16 2004-06-16 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs

Publications (1)

Publication Number Publication Date
SI1644389T1 true SI1644389T1 (sl) 2011-06-30

Family

ID=33551859

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431649T SI1644389T1 (sl) 2003-06-16 2004-06-16 Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi

Country Status (16)

Country Link
US (2) US7115592B2 (sl)
EP (1) EP1644389B1 (sl)
JP (2) JP5280631B2 (sl)
KR (1) KR101102815B1 (sl)
CN (1) CN1805966B (sl)
AT (1) ATE496056T1 (sl)
AU (1) AU2004247305B2 (sl)
CA (1) CA2527805C (sl)
DE (1) DE602004031115D1 (sl)
DK (1) DK1644389T3 (sl)
EA (1) EA011948B1 (sl)
HK (1) HK1088013A1 (sl)
IL (1) IL172015A (sl)
NZ (1) NZ543864A (sl)
SI (1) SI1644389T1 (sl)
WO (1) WO2004111064A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502964A (ja) * 2005-07-27 2009-01-29 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖを阻害するための抗ウイルス性ホスホン酸結合体
FR2908133B1 (fr) 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
AU2011239560B2 (en) 2010-04-14 2016-11-03 The Regents Of The University Of California Phosphonates with reduced toxicity for treatment of viral infections
EP2611818B1 (en) * 2010-08-31 2016-08-24 Chimerix, Inc. Phosphonate ester derivatives and methods of synthesis thereof
CA2810011A1 (en) * 2010-09-01 2012-03-08 Novartis Ag Adsorption of immunopotentiators to insoluble metal salts
JP5932829B2 (ja) 2010-12-10 2016-06-08 シグマファーム ラボラトリーズ エルエルシー 経口活性ヌクレオチドアナログ又は経口活性ヌクレオチドアナログプロドラッグの高度に安定な組成物
KR20140026392A (ko) 2011-03-02 2014-03-05 노파르티스 아게 저용량의 항원 및/또는 보조제를 갖는 조합 백신
EP2794624B1 (en) 2011-12-22 2019-05-15 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
RU2014140521A (ru) 2012-03-08 2016-04-27 Новартис Аг Адъювантные составы бустерных вакцин
CN103665043B (zh) * 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
CN102796138B (zh) * 2012-09-07 2014-10-22 山东大学 (2-(3-甲硫基-1,2,4-噻二嗪)乙氧基)甲基膦酸酯类衍生物及其制备与应用
PT2970346T (pt) 2013-03-15 2018-11-09 Univ California Diésteres de fosfonato nucleosídico acíclico
EP3194411B1 (en) 2014-09-15 2022-05-04 The Regents of the University of California Nucleotide analogs
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
DE3580384D1 (de) 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
EP0232276B1 (de) * 1985-10-30 1988-12-07 Planert, Jens, Dr. med dent. Vorrichtung zum entfernen von kronen, brücken o. dgl. von zahnstümpfen
US5141752A (en) 1986-05-09 1992-08-25 Alza Corporation Delayed drug delivery device
CS264222B1 (en) 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
CA2001715C (en) 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
US5098443A (en) 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
CA2479846C (en) 1989-05-15 2007-07-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Scienc Es Of The Czech Republic Phosphonomethoxymethylpurine/pyrimidine derivatives
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5302585A (en) 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
SK280313B6 (sk) 1990-04-24 1999-11-08 �Stav Organick� Chemie A Biochemie Av �R N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
WO1992001698A1 (en) 1990-07-19 1992-02-06 Beecham Group Plc Antiviral phosphono-alken derivatives of purines
EP0468119A1 (en) 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
DE69129650T2 (de) 1990-09-14 1999-03-25 Acad Of Science Czech Republic Wirkstoffvorläufer von Phosphonaten
US5208221A (en) 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
CZ284678B6 (cs) 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
JP3497505B2 (ja) 1991-10-11 2004-02-16 インスティテュート オブ オルガニック ケミストリー アンド バイオケミストリー オブ ザ アカデミー オブ サイエンシズ オブ ザ チェコ パブリック 抗ウイルス性非環式ホスホノメトキシアルキル置換アルケニル及びアルキニルプリン及びピリミジン誘導体
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
EP0618214A1 (en) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
BR9407510A (pt) 1993-09-17 1997-01-07 Gilead Sciences Inc Análogos de nucleotideo
HU228450B1 (en) 1995-02-27 2013-03-28 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
CA2261619C (en) 1996-07-26 2006-05-23 Gilead Sciences, Inc. Nucleotide analogs
WO2003002580A1 (en) * 2001-06-29 2003-01-09 Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity

Also Published As

Publication number Publication date
US20060241081A1 (en) 2006-10-26
JP2006527702A (ja) 2006-12-07
WO2004111064A1 (en) 2004-12-23
EP1644389B1 (en) 2011-01-19
DK1644389T3 (da) 2011-05-09
NZ543864A (en) 2009-10-30
AU2004247305A1 (en) 2004-12-23
CN1805966A (zh) 2006-07-19
AU2004247305B2 (en) 2010-02-18
DE602004031115D1 (de) 2011-03-03
EA200600046A1 (ru) 2006-06-30
JP2012153731A (ja) 2012-08-16
IL172015A0 (en) 2009-02-11
US7115592B2 (en) 2006-10-03
EP1644389A1 (en) 2006-04-12
EA011948B1 (ru) 2009-06-30
KR20060041182A (ko) 2006-05-11
ATE496056T1 (de) 2011-02-15
CN1805966B (zh) 2013-03-13
CA2527805A1 (en) 2004-12-23
JP5280631B2 (ja) 2013-09-04
US20050075318A1 (en) 2005-04-07
HK1088013A1 (en) 2006-10-27
CA2527805C (en) 2012-08-21
KR101102815B1 (ko) 2012-01-05
IL172015A (en) 2016-07-31

Similar Documents

Publication Publication Date Title
IL172015A0 (en) Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
MXPA05011643A (es) 5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension.
PL369740A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
HK1068626A1 (en) Chemical compounds
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
WO2002098865A3 (fr) Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
HK1085944A1 (en) Antiviral phosphonate analogs
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
GB0100889D0 (en) Compounds
MXPA03009600A (es) Analogos de nociceptina.
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
IL176075A0 (en) Process for fluorocytidine derivatives
SE9904108D0 (sv) Nya föreningar
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA03009602A (es) Analogos de nociceptina.
DE60336735D1 (de) Neue biologischaktive molekü le
IL150061A0 (en) Purine derivatives
GB0317920D0 (en) Solid-phase synthesis
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
WO2004048380A8 (en) Process for the synthesis of ganciclovir
GB0327323D0 (en) Novel pharmaceuticals
TW200616624A (en) 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
ITMI20020933A1 (it) Procedimento per la sintesi di clopidogrel